Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Use of human hepatocyte-like cells derived from induced pluripotent stem cells as a model for hepatocytes in hepatitis C virus infection.
Yoshida T, Takayama K, Kondoh M, Sakurai F, Tani H, Sakamoto N, Matsuura Y, Mizuguchi H, Yagi K.
Biochem Biophys Res Commun. 2011 Dec 9;416(1-2):119-24. Epub 2011 Nov 10.
Related citations
Potent and selective inhibition of hepatitis C virus replication by novel phenanthridinone derivatives.
Salim MT, Aoyama H, Sugita K, Watashi K, Wakita T, Hamasaki T, Okamoto M, Urata Y, Hashimoto Y, Baba M.
Biochem Biophys Res Commun. 2011 Dec 2;415(4):714-9. Epub 2011 Nov 9.
Impact of host responses on control of hepatitis C virus infection in Chinese blood donors.
Li T, Chen Z, Zeng J, Zhang J, Wang W, Zhang L, Zheng X, Shuai L, Klenerman P, Allain JP, Li C.
Biochem Biophys Res Commun. 2011 Nov 25;415(3):503-8. Epub 2011 Oct 29.
Packaging of HCV-RNA into lentiviral vector.
Caval V, Piver E, Ivanyi-Nagy R, Darlix JL, Pagès JC.
Biochem Biophys Res Commun. 2011 Nov 4;414(4):808-13. Epub 2011 Oct 8.
Divergent quasispecies evolution in de novo hepatitis C virus infection associated with bone marrow transplantation.
Wang W, Lin J, Tan D, Xu Y, Brunt EM, Fan X, Di Bisceglie AM.
Biochem Biophys Res Commun. 2011 Oct 14;414(1):148-52. Epub 2011 Sep 16.
Alterations in microRNA expression profile in HCV-infected hepatoma cells: involvement of miR-491 in regulation of HCV replication via the PI3 kinase/Akt pathway.
Ishida H, Tatsumi T, Hosui A, Nawa T, Kodama T, Shimizu S, Hikita H, Hiramatsu N, Kanto T, Hayashi N, Takehara T.
Biochem Biophys Res Commun. 2011 Aug 19;412(1):92-7. Epub 2011 Jul 23.
Development of recombinant hepatitis C virus with NS5A from strains of genotypes 1 and 2.
Okamoto Y, Masaki T, Murayama A, Munakata T, Nomoto A, Nakamoto S, Yokosuka O, Watanabe H, Wakita T, Kato T.
Biochem Biophys Res Commun. 2011 Jul 8;410(3):404-9. Epub 2011 Jun 6.
Plural assay systems derived from different cell lines and hepatitis C virus strains are required for the objective evaluation of anti-hepatitis C virus reagents.
Ueda Y, Mori K, Ariumi Y, Ikeda M, Kato N.
Biochem Biophys Res Commun. 2011 Jun 17;409(4):663-8. Epub 2011 May 17.
HCV-induced PKR activation is stimulated by the mitogen- and stress-activated protein kinase MSK2.
Kang JI, Ahn BY.
Biochem Biophys Res Commun. 2011 Apr 1;407(1):248-53. Epub 2011 Mar 6.
Hepatitis C virus RNA replication in human stellate cells regulates gene expression of extracellular matrix-related molecules.
Watanabe N, Aizaki H, Matsuura T, Kojima S, Wakita T, Suzuki T.
Biochem Biophys Res Commun. 2011 Apr 1;407(1):135-40. Epub 2011 Mar 1.
Visualization of the structures of the hepatitis C virus replication complex.
Chan SC, Lo SY, Liou JW, Lin MC, Syu CL, Lai MJ, Chen YC, Li HC.
Biochem Biophys Res Commun. 2011 Jan 7;404(1):574-8. Epub 2010 Dec 11.
Hepatitis C virus nonstructural protein-5A activates sterol regulatory element-binding protein-1c through transcription factor Sp1.
Xiang Z, Qiao L, Zhou Y, Babiuk LA, Liu Q.
Biochem Biophys Res Commun. 2010 Nov 19;402(3):549-53. Epub 2010 Oct 29.
Dynamics of lipid droplets induced by the hepatitis C virus core protein.
Lyn RK, Kennedy DC, Stolow A, Ridsdale A, Pezacki JP.
Biochem Biophys Res Commun. 2010 Sep 3;399(4):518-24. Epub 2010 Aug 1.
Biological properties of purified recombinant HCV particles with an epitope-tagged envelope.
Takahashi H, Akazawa D, Kato T, Date T, Shirakura M, Nakamura N, Mochizuki H, Tanaka-Kaneko K, Sata T, Tanaka Y, Mizokami M, Suzuki T, Wakita T.
Biochem Biophys Res Commun. 2010 May 14;395(4):565-71. Epub 2010 Apr 23.
Real-time monitoring of RNA helicase activity using fluorescence resonance energy transfer in vitro.
Tani H, Fujita O, Furuta A, Matsuda Y, Miyata R, Akimitsu N, Tanaka J, Tsuneda S, Sekiguchi Y, Noda N.
Biochem Biophys Res Commun. 2010 Feb 26;393(1):131-6. Epub 2010 Feb 1.
Chronic hepatitis C viral infection reduces NK cell frequency and suppresses cytokine secretion: Reversion by anti-viral treatment.
Dessouki O, Kamiya Y, Nagahama H, Tanaka M, Suzu S, Sasaki Y, Okada S.
Biochem Biophys Res Commun. 2010 Mar 5;393(2):331-7. Epub 2010 Feb 6.
2',5'-Oligoadenylate synthetase-like gene highly induced by hepatitis C virus infection in human liver is inhibitory to viral replication in vitro.
Ishibashi M, Wakita T, Esumi M.
Biochem Biophys Res Commun. 2010 Feb 12;392(3):397-402. Epub 2010 Jan 13.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on